A series of potential biomarkers were recorded in DMD patients and animal models, including mdx mice, dystrophin/utrophin double-knockout (dKO) mice, golden retriever muscular dystrophy (GRMD), and canine X-linked MD in Japan dogs (CXMDJ). This evidence concerns the gene DMD and Duchenne muscular dystrophy.